GABRIELLE NICOLLE: Open Payments
NPI 1578826772 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,921 in 163 payments from 23 companies in 2025. Trend: 2023 $2,747 · 2024 $2,236 · 2025 $2,921
Food & beverage: $2,921
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $729 |
| Amgen Inc. | 37 | $635 |
| UCB, Inc. | 21 | $390 |
| Novartis Pharmaceuticals Corporation | 17 | $289 |
| Janssen Biotech, Inc. | 10 | $175 |
| Mallinckrodt Hospital Products Inc. | 5 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $93 |
| Dexcom, Inc. | 4 | $75 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| GENZYME CORPORATION | 3 | $63 |
Products named: RINVOQ, Bimzelx, KRYSTEXXA, COSENTYX, TREMFYA, OTEZLA, SKYRIZI, ACTHAR.
Industry payments across LA — which companies pay providers there.
